The FDA approval of a promising new drug is offering new hope to multiple myeloma patients who have already been through various treatments.
daratumumab
-
March 18, 2016
-
February 24, 2016
Multiple myeloma is a treatable but incurable blood cancer that typically occurs in the bone marrow.